Blue Trust’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
Blue Trust's RDY Position: Q3 2026 in Review
Blue Trust reduced its Dr. Reddy's Laboratories (RDY) stake by 64% in Q3 2026, selling an estimated $247K and leaving 11,177 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #890.
Blue Trust first reported a position in RDY in Q2 2022 and has held it in 18 quarters since. The position peaked at $948K in Q3 2024. 185 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- Blue Trust held 11,177 shares of Dr. Reddy's Laboratories worth $141K as of Q3 2026.
- Blue Trust sold 19,946 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $247K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #890 holding.
- Blue Trust first reported a position in Dr. Reddy's Laboratories in Q2 2022 and has held it in 18 quarters since.
- Blue Trust's Dr. Reddy's Laboratories position peaked at $948K in Q3 2024.
- 185 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.